Amgen, Inc. (AMGN)
349.38
+1.16
(+0.33%)
USD |
NASDAQ |
Apr 16, 16:00
350.50
+1.12
(+0.32%)
After-Hours: 20:00
Amgen Market Cap : 188.34B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.83B |
| Gilead Sciences, Inc. | 171.97B |
| Johnson & Johnson | 565.01B |
| Regeneron Pharmaceuticals, Inc. | 78.87B |
| Moderna, Inc. | 21.70B |
Market Cap Related Metrics
| PE Ratio | 24.55 |
| PS Ratio | 5.152 |
| PEG Ratio | 0.2770 |
| Price to Book Value | 21.75 |
| Price to Free Cash Flow | 23.37 |
| Price | 349.38 |
| Earnings Yield | 4.07% |
| PEGY Ratio | 0.2686 |
| Operating PE Ratio | 18.44 |
| Normalized PE Ratio | 22.22 |